Home > Riviste > Italian Journal of Vascular and Endovascular Surgery > Fascicoli precedenti > Italian Journal of Vascular and Endovascular Surgery 2017 March;24(1) > Italian Journal of Vascular and Endovascular Surgery 2017 March;24(1):19-25

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Per citare questo articolo

 

SPECIAL ARTICLE   

Italian Journal of Vascular and Endovascular Surgery 2017 March;24(1):19-25

DOI: 10.23736/S1824-4777.17.01272-4

Copyright © 2017 EDIZIONI MINERVA MEDICA

lingua: Inglese

Current management of aorto-iliac aneurysms

Pascal DESGRANGES 1, Hicham KOBEITER 2, Frederic COCHENNEC 1, Joseph TOUMA 1, Marek MAJEWSKI 1, Jean MARZELLE 1

1 Vascular Surgery Unit, Henri Mondor Hospital, Public Assistance Hospital of Paris, Paris, France; 2 Radiology Unit, Henri Mondor Hospital, Public Assistance Hospital of Paris, Paris, France


PDF


The vast majority of AAA is now treated by endovascular therapy (EVAR), as the current generation of devices has reduced device-related complications, with fair long-term results as long as surgeons comply with IFU, i.e. in favorable anatomies. Although there will always remain indications for open repair (OR), technological and technical advances such as fenestrated/branched endografts, parallel grafts and endovascular sealing of the aneurysm, will probably further reduce indications for OR. The major drawback of EVAR is the need for long-term surveillance in order to prevent the risk of late rupture.


KEY WORDS: Aortic aneurysm, abdominal - Surgical proceduresm operative - Aneurysm, ruptured - Complications

inizio pagina